We did not confirm the results observed in colon cancer patients with low HRV (SDNN ≤20 ms), who had significantly higher CEA levels at 12 months than those with higher HRV, independent of other clinical variables (25). This evidence concerns the gene CEACAM5 and malignant colon neoplasm.